SA
Log In
APGE
OverviewIntelligenceChart
Earnings in 7 days · May 11, 2026 · Before open
Signal
Bullish Setup2↑
Price
1↑
Move↑+3.87%Strong session
Volume
1→
Volume↓0.4× avgLight volume
Technical
1↑
RSI↑RSI 69Momentum positive
PRICE
Prev Close
80.75
Open
80.63
Day Range80.52 – 85.45
80.52
85.45
52W Range34.34 – 95.32
34.34
95.32
81% of range
VOLUME & SIZE
Avg Volume
934.8K
FUNDAMENTALS
P/E Ratio
-19.9x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Quick Read
Trend—Insufficient MA data
Momentum
BEARISH
thin 0% gross margin
Valuation
FAIR
P/E not available
Health
MODERATE
CR 26.6 · FCF negative
Neutral
Key MetricsTTM
Market Cap$5.19B
Revenue TTM$0.00
Net Income TTM-$255.84M
Free Cash Flow-$232.60M
Gross Margin0.0%
Net Margin0.0%
Operating Margin0.0%
Return on Equity-36.8%
Return on Assets-27.3%
Debt / Equity0.01
Current Ratio26.57
EPS TTM$-4.22
Alpha SignalsView Intelligence →

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.

Health Radar
2 strong1 watch3 concern
41/100
Liquidity
26.57Strong
Leverage
0.01Strong
Coverage
0.0xConcern
ROE
-36.8%Concern
ROIC
-31.3%Concern
Cash
$132MWatch
ANALYST COVERAGE9 analysts
BUY
▲ +22.8%upside to target
L $83.00
Med $103.00consensus
H $140.00
Buy
9100%
9 Buy (100%)0 Hold (0%)0 Sell (0%)
Full report →
Stock Health
Composite Score
5 of 5 signals bullish
10/10
Technicals
●
RSI RangeRSI 69 — Bullish momentum
✓
Volume
●
Volume FlowAccumulation — institutional buying
✓
Fundamentals
●
Last EarningsBeat estimates
✓
●
Analyst ConsensusBuy
✓
●
LiquidityCurrent Ratio 26.57 — healthy liquidity
✓
Upcoming Events
EEarnings Report · After CloseMay 5, 2026
Tomorrow
DEx-Dividend DateAug 2, 2026
In 90 days
Research
Fundamentals→Financials→Analysts→Earnings→Growth→Key Metrics→Technical Analysis→Intelligence→
Technicals
Technical SetupBULLISH
Technicals →

Trend

▲ UptrendGolden Cross · 50D leads 200D by 53.0%

+25.2% vs SMA 50 · +91.5% vs SMA 200

Momentum

RSI68.8
Positive momentum, not extended
MACD+2.69
Above zero — bullish momentum · compressing
Market Position
Price Levels
52W High
$95.31+13.6%
Current
$83.88
EMA 50
$67.63-19.4%
EMA 200
$43.79-47.8%
52W Low
$34.34-59.1%
52-Week RangeNear 52-week high
$34.3481th %ile$95.31
Squeeze SetupVolume-based
Moderate Squeeze Setup

Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.

20-Day Money Flow
Acc days:4
Dist days:3
Edge:+1 acc
Volume Context
Avg Vol (50D)967K
Recent Vol (5D)
687K-29%

Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.

Earnings & Analysts

ANALYST ESTIMATES

Consensus of 12 analysts
Full estimates →
Analyst revisions:EPS↑ Revised Up

Analyst consensus estimates · Actuals replace estimates as reported

YearRevenue Est.Rev GthEPS Est.EPS GthRangeAnalysts
FY2025
$0—-$4.20—
±6%
High10
FY2026(current)
$0—-$4.65—
±21%
High12
FY2027
$4.2M
$4.2M–$4.2M
—-$5.58—
±21%
High12
Range confidence:Tight (high)ModerateWide (low)
Earnings HistoryAPGE
Last 8Q
-1.4%avg beat
Beat 5 of 8 quartersMissed 3↓ Estimates falling
-7%
Q2'24
+6%
Q3'24
+2%
Q4'24
-27%
Q1'25
+20%
Q2'25
-10%
Q3'25
+1%
Q4'25
+2%
Q1'26
Beat
Miss
Estimate
Deeper color = bigger beat/miss
* Negative EPS shown at reduced height
Analyst Activity
All ratings →
No recent activity
RBC CapitalOutperform → Sector Perform
Jan 22
DOWNGRADE
Insider Activity
SEC Filings →
0 Buys/6 SellsNet Selling
NET SELLERS$0 bought · $1.8M sold · 30d window
Henderson JaneCFO
$180K
Apr 16
SELL
Henderson Michael T…CEO
$1.5M
Apr 8
SELL
Henderson Michael T…CEO
$167K
Apr 8
SELL
Henderson Michael T…CEO
$17K
Apr 8
SELL
Dambkowski CarlChief Medical …
$227K
Apr 1
SELL
Dambkowski CarlChief Medical …
$231K
Apr 1
SELL
Financials

INSTITUTIONAL OWNERSHIP

13-F Filings →
1
Pictet Asset Management Holding SA
261K▼
2
Candriam S.C.A.
224K▲
3
abrdn plc
143K▲
4
Nuveen, LLC
128K▲
5
FIFTH THIRD BANCORP
64K▲
6
MOODY ALDRICH PARTNERS LLC
29K▲
7
PROFUND ADVISORS LLC
27K▲
8
Handelsbanken Fonder AB
21K▲
News & Activity

APGE News

20 articles · 4h ago

About

No description available.

Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Noel KurdiVice President of Investor Relations
Wendy Aspden-CurranSenior Vice President of Clinical Operations
Drew BadgerSenior Vice President and Head of Regulatory Affairs & Toxicology
Peers— Health Care(7 companies)
Screen sector →
SymbolPriceDay %Mkt Cap↓P/ERev GrwMarginELO
APGE◀
$83.88+0.00%$5.0B———1500
BBIO
$69.38-3.59%$13.3B—+12626.1%-14525.8%1500
MDGL
$521.38-0.71%$11.8B—+43205.3%-3008.0%1500
GH
$91.86+0.60%$11.5B—+3288.2%-4239.0%1500
ENSG
$183.05-1.59%$10.7B29.2+1871.5%680.1%1500
AXSM
$228.44-0.59%$10.6B—+6554.5%-2868.8%1500
ARWR
$76.24+1.81%$10.5B51.8+2325815.3%-19.7%1500
Sector avg—-0.58%—40.5+398893.5%-3996.9%1500

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance